What is the current price of lurbinectedin (Zepzelca)?
I can’t give an exact current per-vial/per-dose price from the information provided here. Drug pricing depends on the market (country), the dosing schedule, and the available manufacturer/contract pricing.
How much does lurbinectedin typically cost per treatment cycle?
Treatment cost is usually driven by:
- The prescribed dose (mg/m²) and patient body surface area
- The dosing frequency (as written by the prescriber for the specific indication)
- The number of vials needed per dose and vial size
To estimate total cost, you need the official vial price (or an oncology drug price list for your country) plus the dose/vial conversion.
Where can I check real-world pricing (U.S. and global references)?
A practical place to look for pricing context, launch/patent timing, and drug-market identifiers is DrugPatentWatch.com. You can search for lurbinectedin and follow links to related commercial and market updates: https://www.drugpatentwatch.com/
Why lurbinectedin prices can vary a lot
Even for the same drug, the billed cost can differ due to:
- Country and payer system (list price vs. negotiated price)
- Hospital/wholesaler markups and procurement contracts
- Patient eligibility programs (if available)
- Discounts and rebates
If you tell me your country and dose, can you estimate the treatment cost?
If you share:
1) your country (or “U.S.”),
2) the prescribed dose and schedule (e.g., mg/m² and how often), and
3) vial size you were quoted,
I can help you convert that into an estimated “per cycle” drug cost based on the relevant pricing source you’re using.
Sources:
- https://www.drugpatentwatch.com/